Nu-Med Plus (NUMD) Tax Provisions (2016 - 2018)

Nu-Med Plus (NUMD) reported Tax Provisions of $100.0 for Q4 2018, up 200.0% sequentially from -$100.0 in Q4 2016.

Nu-Med Plus (NUMD) Tax Provisions (2016 - 2018) Analysis & Trends

Nu-Med Plus (NUMD) has 2 years of Tax Provisions data on file, last reported at $100.0 in Q4 2018.

For the quarter ending Q4 2018, Tax Provisions changed N/A year-over-year to $100.0; the trailing twelve-month figure through Sep 2019 stood at $100.0 (changed N/A YoY), and the FY2018 full-year result was $100.0, changed N/A from the prior year.
Tax Provisions improved to $100.0 in Q4 2018, from -$100.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $100.0 in Q4 2018 to a low of -$100.0 in Q4 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	372.00 Mn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	105.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	575.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-176.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	78.30 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	70.00 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-51.51 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	94.00 Mn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Nu-Med Plus	1.67 Mn	1.67 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2018	100.00
Dec 31, 2016	-100.00